Delivery Order SPE2DB20D3103-SPE2DB24FP7M3
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The contract has a ceiling value of $4,172.08 and a completion date of January 23, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,058.36, is for the delivery of Exforge 5-320 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of March 17, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corporation's Corporate Office division. The $3,221.03 firm fixed price contract is for the delivery of Exforge 5-160 mg tablets, a prescription medication. The award is not set aside and is part of Amerisourcebergen's broader IDC with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.10, is a Firm Fixed Price Delivery Order for the supply of EXFORGE 5-160 MG TABLET 30S. The contract has an ultimate completion date of January 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,023.95, is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through January 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award is for the delivery of Exforge 5-160 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $1,812.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 7, 2023, with a completion date of June 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,510.64, is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) running through January 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999 IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EXFORGE HCT 10-320-25 MG TAB 30S, a prescription medication. The contract has a ceiling value of $3,780.26 and runs through October 16, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will be responsible for providing the...